Company Overview
Snapshot
Founded in July 2021 by Anat Horev and Bilha Cahana, Vflow21 operates with 1–10 employees. The company has secured funding across two rounds from Sanara Capital and Israel Innovation Authority, with its most recent funding round in April 2025.
Business overview
Vflow21 is a medical device company focused on developing innovative solutions for neurovascular diseases. The company's core technology addresses conditions such as Idiopathic Intracranial Hypertension and Tinnitus, operating within the Health Tech & Life Sciences sector, specifically targeting Medical Devices and Medical Treatment & Therapeutics.
Log in to access full profile ›Company Intelligence Q&A
- When was Vflow21 founded and by whom?
- Vflow21 was founded in July 2021 by co-CEOs Anat Horev and Bilha Cahana.
- What is Vflow21's primary focus in the medical device sector?
- Vflow21 specializes in developing innovative solutions for neurovascular diseases, with a particular focus on Idiopathic Intracranial Hypertension and Tinnitus treatment.